Traces of the SARS-CoV-2 coronavirus that causes COVID-19 can be detected in breath tests

Traces of the SARS-CoV-2 coronavirus that causes COVID-19 can be detected in microscopically small fluid droplets exhaled during a very short time span. This is the finding of a new study from the University of Gothenburg. The measurement was carried out primarily with an advanced research instrument developed by the publishing research team.

The findings have now been published in the journal Influenza and Other Respiratory Viruses. The measurements were made with the research instrument Particles in Exhaled Air (PExA), developed at Occupational and Environmental Medicine at Sahlgrenska Academy, and with a smaller handheld instrument called the Breath Explor (BE).

Infection spread with exhaled air is well known, but now the researchers show that a few breaths are sufficient for detecting traces of viruses in microscopically small fluid droplets (i.e. particles) exhaled from small airways, at least early in the course of COVID-19.

“We show that aerosol particles with the ribonucleic acid (RNA) virus can be found early in the course of COVID-19. The particles we can detect are very small-less than five micrometers in diameter-and we have here managed to capture particles with RNA virus in just a few breaths,” said Emilia Viklund, a doctoral student in occupational and environmental medicine and lead author of the study.

Affects in the small airways

Of course, this immediately leads to conjecture about possibly replacing unpleasant nasal swab tests with convenient and easy breath tests. However, according to Professor Anna-Carin Olin, the inventor of PExA, that would be extrapolating the findings too far.

“Respiratory viruses such as SARS-CoV-2 are likely to be concentrated mainly in the nose and throat, and it is easiest to take samples from that mucous membrane to detect the infection,” says Professor Olin.

“In contrast, the method of taking measurement in exhaled air is a very promising way of studying how the virus affects the small respiratory airways and how this effect changes during the course of the disease. Among other things, we are working on studies of post-COVID conditions using this method.”

Emilia Viklund says, “Methods for studying aerosol particles can be a good way of complementing established methods of measuring and monitoring COVID-19. In general, we can say that analysis of exhaled air has great potential for studying the spread of infection and where the virus is in the respiratory tract.”

Difficult to recruit study subjects

The idea of trying to measure viruses and signs of changes in the small respiratory passages using PExA originated early in 2020, when the pandemic was an established fact. One challenge has been recruiting study subjects early in the course of the disease, despite close collaboration with the research team of the study’s co-author, Professor Johan Westin, in the Department of Infectious Diseases.

In an initial small study involving only 10 subjects conducted in the autumn of 2020, only one of the samples was positive. The researchers believe this resulted from conducting measurements too late in the course of the disease.

In collaboration with Sahlgrenska University Hospital, which allowed parallel measurement in connection with employees taking polymerase chain reaction (PCR) tests on the hospital grounds, the study eventually evolved to include more subjects in an earlier stage of the disease. These measurements were conducted in the spring of 2021 on medical professionals who had just submitted positive PCR samples for COVID-19.

Three different techniques were used to collect the samples: 20 normal breaths; a technique in which study subjects briefly hold their breath after a very deep exhalation; and a technique in which the study subject coughed three times into the instrument.

Extremely small samples

The research shows unsurprisingly that coughing generated the most positive breath samples collected with PExA (8 of 25), followed by deep breathing (3 of 25) and regular breathing (2 of 25). Two positive aerosol samples from normal respiration were also generated when collected with the instrument Breath Explor, although these came from individuals who were separate from the PExA findings with normal respiration.

“The quantity of aerosol particles we needed for the test was about one 10-millionth of the amount from nasal swab samples needed to detect viral RNA in regular respiration with PCR analysis,” says Anna-Carin Olin. “The findings from the deep-breathing maneuver came as a surprise, the amount of sample is minute.

Fluid droplets that one exhales after deep breathing form largely in the small airways, where it is known that the virus can cause great damage. As a result, it would be exciting to further study the findings in the exhaled air in relation to disease progression.”

Continued research

The Alpha viral variant dominated when surveys were conducted, which caused infection that often extended farther down into the lungs compared with the now dominant Omicron variant. New studies underway will help explain how the complement system in small respiratory passages is activated, whether the response looks different when viruses change, and the long-term effects on small respiratory passages in the case of post-COVID syndrome.

Emilia Viklund is essentially a biomedical analyst, focusing on physiological investigations. The study now becomes part of her thesis, which she is scheduled to defend in early summer.

The other contributing papers also involve measuring small particles with PExA and other methods of lung function measurements, but in that case in connection with smoking and asthma.

Story source:

University of Gothenburg

Journal Reference

Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing

Abstract:

Background
The knowledge on the concentration of viral particles in exhaled breath is limited. The aim of this study was to explore if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be detected in aerosol from subjects with the coronavirus disease 2019 (COVID-19) during various types of breathing and coughing and how infection with SARS-CoV-2 may influence the number and size of exhaled aerosol particles.

Methods

We counted and collected endogenous particles in exhaled breath in subjects with COVID-19 disease by two different impaction-based methods, during 20 normal breaths, 10 airway opening breaths, and three coughs, respectively. Breath samples were analyzed with reverse transcription real-time polymerase chain reaction (RT-PCR).

Results
Detection of RNA in aerosol was possible in 10 out of 25 subjects. Presence of virus RNA in aerosol was mainly found in cough samples (n = 8), but also in airway opening breaths (n = 3) and in normal breaths (n = 4), with no overlap between the methods.

No association between viral load in aerosol and number exhaled particles <5 μm was found. Subjects with COVID-19 exhaled less particles than healthy controls during normal breathing and airway opening breaths (all P < 0.05), but not during cough.

Conclusion
SARS-CoV-2 RNA can be detected in exhaled aerosol, sampled during a limited number of breathing and coughing procedures. Detection in aerosol seemed independent of viral load in the upper airway swab as well as of the exhaled number of particles. The infectious potential of the amount of virus detected in aerosol needs to be further explored.